• 888 holdings: Investec maintains its buy recommendation and reduces the target price from GBX 190 to GBX 140.
  • Abbott lab: Citi maintains its buy recommendation and reduces the target price from USD 130 to USD 122.
  • Amgen inc: Barclays maintains its underweight recommendation with a price target raised from USD 210 to USD 230.
  • Antofagasta plc: Citi upgrades to buy from neutral with a price target raised from GBP 15 to GBP 17.
  • Bae systems plc: Berenberg upgrades to buy from hold with a price target raised from GBX 1050 to GBX 1170.
  • Baxter int: Citi maintains its neutral recommendation with a price target reduced from USD 45 to USD 41.
  • Best buy: Baptista Research upgrades to outperform from hold with a price target reduced from USD 83.10 to USD 82.20.
  • Bristol-myer: Barclays maintains its equalweight recommendation and reduces the target price from USD 62 to USD 60.
  • Bt group plc: Berenberg maintains its hold recommendation with a price target reduced from GBP 1.50 to GBP 1.35.
  • Carnival corp: Susquehanna maintains a positive recommendation with a price target reduced from USD 17 to USD 16.
  • Celanese corp: BMO Capital Markets maintains its market perform recommendation with a price target raised from USD 119 to USD 138.
  • Comcast corp-a: Goldman Sachs maintains its buy recommendation and raises the target price from USD 51 to USD 52.
  • Cooper cos inc: Citi maintains its buy recommendation with a price target reduced from USD 440 to USD 420.
  • Datadog inc-a: Piper Sandler & Co upgrades to overweight from neutral with a price target raised from USD 88 to USD 115.
  • Dexcom: Citi maintains its buy recommendation with a price target reduced from USD 150 to USD 115.
  • Edwards life: Citi maintains its buy recommendation and reduces the target price from USD 110 to USD 94.
  • Expeditors: BNP Paribas Exane maintains its neutral recommendation with a price target raised from USD 108 to USD 109.
  • Fedex corp: BNP Paribas Exane maintains its neutral recommendation with a price target raised from USD 220 to USD 280.
  • Gamma communicat: Numis maintains its buy recommendation with a price target reduced from GBX 2070 to GBX 2025.
  • Ig group holding: Canaccord Genuity upgrades to buy from sell with a price target raised from GBX 667 to GBX 801.
  • Imi plc: Investec maintains its buy recommendation and raises the target price from GBX 1900 to GBX 1950.
  • Insulet corp: Jefferies upgrades to buy from hold with a price target reduced from USD 260 to USD 240.
  • M&g plc: Deutsche Bank maintains its hold recommendation with a price target raised from GBX 220 to GBX 230.
  • Moody's corp: Goldman Sachs maintains its neutral recommendation with a price target reduced from USD 375 to USD 350.
  • Mosaic: Berenberg maintains its hold recommendation with a price target raised from USD 38 to USD 41.
  • Natwest group pl: Morgan Stanley downgrades to equalwt from overwt with a target price reduced from GBX 320 to GBX 310.
  • Next plc: Investec maintains its hold recommendation with a price target raised from GBX 6802 to GBX 7175.
  • Nextera energy: Goldman Sachs maintains its buy recommendation with a price target reduced from USD 83 to USD 72.
  • Nextera energy: Wells Fargo maintains its overweight rating and reduces the target price from USD 105 to USD 84.
  • Nike inc -cl b: KGI Securities Co Ltd maintains its outperform rating and reduces the target price from USD 144 to USD 130.
  • Okta: Morgan Stanley maintains its equalwt/attractive rating and reduces the target price from USD 89 to USD 85.
  • Pagegroup plc: Jefferies upgrades to hold from underperform with a price target raised from GBX 375 to GBX 420.
  • Pfizer: Barclays maintains its equalweight recommendation and reduces the target price from USD 38 to USD 35.
  • Philip morris in: SBG Securities (Pty) Ltd maintains its buy recommendation with a price target reduced from USD 112 to USD 108.
  • Playtech plc: Investec maintains its buy recommendation and raises the target price from GBX 838 to GBX 870.
  • Qualcomm: JP Morgan maintains its overweight rating and reduces the target price from USD 148 to USD 135.
  • Renew holdings: Peel Hunt maintains its buy recommendation with a price target raised from GBX 900 to GBX 950.
  • Rtx: Bernstein maintains its market perform recommendation and reduces the target price from USD 91 to USD 77.
  • S&p global: Goldman Sachs maintains its buy recommendation and raises the target price from USD 456 to USD 457.
  • Schlumberger: JP Morgan maintains its overweight recommendation with a price target raised from USD 60 to USD 65.
  • Solaredge techno: Barclays downgrades to equalweight from overweight with a price target reduced from USD 274 to USD 152.
  • Splunk inc: Piper Sandler & Co downgrades to neutral from overweight with a target price of USD 157.
  • Stryker corp: Citi maintains its buy recommendation with a price target reduced from USD 342 to USD 330.
  • T-mobile us: Goldman Sachs maintains its buy recommendation and reduces the target price from USD 194 to USD 191.
  • United parcel-b: BNP Paribas Exane maintains its underperform recommendation with a price target reduced from USD 166 to USD 130.
  • Zimmer biomet ho: Citi maintains its neutral recommendation with a price target reduced from USD 146 to USD 125.
  • Zscaler: Piper Sandler & Co upgrades to overweight from neutral with a price target raised from USD 160 to USD 190.